相关实验视频
Updated: Jun 29, 2025
04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
377
[肥胖症药物治疗的现状]
1Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung, Korea.
概括
随着患病率的上升,有效的肥胖治疗非常重要. 目前的韩国选择包括奥利斯塔特,纳尔特雷克松/布普罗,胺/托皮拉马特和利拉格卢提德,在全球范围内出现了新的药物.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 药理干预措施 药理干预措施
背景情况:
- 韩国肥胖率不断上升,需要先进的治疗策略.
- 对于许多患者来说,仅仅改变生活方式是不够的.
- 需要有效和安全的长期肥胖管理工具.
研究的目的:
- 审查目前在韩国可长期使用的药理肥胖治疗方法.
- 讨论新兴的肥胖药物及其潜在影响.
- 突出成功治疗肥胖症的考虑因素.
主要方法:
- 关于肥胖治疗方式的文献综述.
- 对韩国目前批准的长期肥胖药物的分析.
- 讨论新兴的药理学药剂及其局限性.
主要成果:
- 韩国已批准四种药物 (奥利斯塔特,纳尔特雷克松/布普罗,芬特明/托皮拉马特,利拉格卢) 用于长期治疗肥胖症.
- 塞马格卢提德和提泽帕提德是有前途的,但尚未提供.
- 限制包括悠悠效应,长期安全性和成本.
结论:
- 对于临床医生和患者来说,全面了解药物优势和副作用至关重要.
- 为了更有效的肥胖治疗,需要继续进行研究和开发.
- 个性化治疗方法对于成功的肥胖管理至关重要.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:23Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
01:24Obesity
498
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
498
01:26Psychosis: Goals of Pharmacotherapy
125
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
125
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127